Reaction
Intravascular Haemolysis reporting signals
As of the last recalculation, Intravascular Haemolysis appears in 550 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is RAVULIZUMAB (PRR 70.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ravulizumab | 24 | 70.2 | 70.4 |
| Eculizumab | 80 | 65.0 | 65.1 |
| Iron Sucrose | 12 | 48.7 | 48.7 |
| Panitumumab | 12 | 29.6 | 29.6 |
| Oxaliplatin | 50 | 28.0 | 28.0 |
| Fluorouracil Cream, 0.5% | 40 | 21.3 | 21.3 |
| Fluorouracil | 40 | 21.0 | 21.0 |
| Aflibercept | 8 | 9.8 | 9.8 |